Search Results - "LaVange, Lisa"

Master Protocols to Study Multiple Therapies, Multiple Diseases, or Both by Woodcock, Janet, LaVange, Lisa M

“…This review considers master protocols, which involve the study of one or more interventions in multiple diseases or of a single disease with multiple…”
Get full text

Discussion on “Improving precision and power in randomized trials for COVID‐19 treatments using covariate adjustment, for binary, ordinal, and time‐to‐event outcomes” by David Benkeser, Ivan Diaz, Alex Luedtke, Jodi Segal, Daniel Scharfstein, and Michael Rosenblum by LaVange, Lisa M.

Get full text

Real-World Evidence — What Is It and What Can It Tell Us? by Sherman, Rachel E, Anderson, Steven A, Dal Pan, Gerald J, Gray, Gerry W, Gross, Thomas, Hunter, Nina L, LaVange, Lisa, Marinac-Dabic, Danica, Marks, Peter W, Robb, Melissa A, Shuren, Jeffrey, Temple, Robert, Woodcock, Janet, Yue, Lilly Q, Califf, Robert M

“…The FDA is developing guidance on the use of “real-world evidence” — health care information from atypical sources, including electronic health records,…”
Get full text

Sample Design and Cohort Selection in the Hispanic Community Health Study/Study of Latinos by LaVange, Lisa M., PhD, Kalsbeek, William D., PhD, Sorlie, Paul D., PhD, Avilés-Santa, Larissa M., MD, MPH, Kaplan, Robert C., PhD, Barnhart, Janice, MD, MS, Liu, Kiang, PhD, Giachello, Aida, PhD, Lee, David J., PhD, Ryan, John, DrPH, Criqui, Michael H., MD, MPH, Elder, John P., PhD, MPH

“…Purpose The Hispanic Community Health Study (HCHS)/Study of Latinos (SOL) is a multicenter, community-based cohort study of Hispanic/Latino adults in the…”
Get full text

A regulatory perspective on missing data in the aftermath of the NRC report by LaVange, Lisa M., Permutt, Thomas

“…The issuance of a report in 2010 by the National Research Council (NRC) of the National Academy of Sciences entitled ‘The Prevention and Treatment of Missing…”
Get full text

Treatment of Adults Hospitalized With COVID-19 Pneumonia-Reply by Powderly, William G, LaVange, Lisa, Bozzette, Samuel A

Get full text

Prevalence of Diabetes Among Hispanics/Latinos From Diverse Backgrounds: The Hispanic Community Health Study/Study of Latinos (HCHS/SOL) by SCHNEIDERMAN, Neil, LLABRE, Maria, YANPING TENG, VILLA-CABALLERO, Leonel, AVILES-SANTA, M. Larissa, COWIE, Catherine C, BARNHART, Janice, CARNETHON, Mercedes, GALLO, Linda C, GIACHELLO, Aida L, HEISS, Gerardo, KAPLAN, Robert C, LAVANGE, Lisa M

“…We examine differences in prevalence of diabetes and rates of awareness and control among adults from diverse Hispanic/Latino backgrounds in the Hispanic…”
Get full text

Design of the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS) by Couper, David, LaVange, Lisa M, Han, MeiLan, Barr, R Graham, Bleecker, Eugene, Hoffman, Eric A, Kanner, Richard, Kleerup, Eric, Martinez, Fernando J, Woodruff, Prescott G, Rennard, Stephen

“…Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS) is a multicentre observational study of chronic obstructive pulmonary disease (COPD)…”
Get more information

Adaptive platform trials: definition, design, conduct and reporting considerations by Angus, Derek C, Alexander, Brian M, Berry, Scott, Buxton, Meredith, Lewis, Roger, Paoloni, Melissa, Webb, Steven A. R, Arnold, Steven, Barker, Anna, Berry, Donald A, Bonten, Marc J. M, Brophy, Mary, Butler, Christopher, Cloughesy, Timothy F, Derde, Lennie P. G, Esserman, Laura J, Ferguson, Ryan, Fiore, Louis, Gaffey, Sarah C, Gaziano, J. Michael, Giusti, Kathy, Goossens, Herman, Heritier, Stephane, Hyman, Bradley, Krams, Michael, Larholt, Kay, LaVange, Lisa M, Lavori, Philip, Lo, Andrew W, London, Alex John, Manax, Victoria, McArthur, Colin, O'Neill, Genevieve, Parmigiani, Giovanni, Perlmutter, Jane, Petzold, Elizabeth A, Ritchie, Craig, Rowan, Kathryn M, Seymour, Christopher W, Shapiro, Nathan I, Simeone, Diane M, Smith, Bradley, Spellberg, Bradley, Stern, Ariel Dora, Trippa, Lorenzo, Trusheim, Mark, Viele, Kert, Wen, Patrick Y, Woodcock, Janet

“…Researchers, clinicians, policymakers and patients are increasingly interested in questions about therapeutic interventions that are difficult or costly to…”
Get full text

Design and Implementation of the Hispanic Community Health Study/Study of Latinos by Sorlie, Paul D., PhD, Avilés-Santa, Larissa M., MD, MPH, Wassertheil-Smoller, Sylvia, PhD, Kaplan, Robert C., PhD, Daviglus, Martha L., MD, PhD, Giachello, Aida L., PhD, Schneiderman, Neil, PhD, Raij, Leopoldo, MD, Talavera, Gregory, MD, MPH, Allison, Matthew, MD, MPH, LaVange, Lisa, PhD, Chambless, Lloyd E., PhD, Heiss, Gerardo, MD, PhD

“…Purpose The Hispanic Community Health Study (HCHS)/Study of Latinos (SOL) is a comprehensive multicenter community based cohort study of Hispanics/Latinos in…”
Get full text

Prevalence of Major Cardiovascular Risk Factors and Cardiovascular Diseases Among Hispanic/Latino Individuals of Diverse Backgrounds in the United States by Daviglus, Martha L, Talavera, Gregory A, Avilés-Santa, M. Larissa, Allison, Matthew, Cai, Jianwen, Criqui, Michael H, Gellman, Marc, Giachello, Aida L, Gouskova, Natalia, Kaplan, Robert C, LaVange, Lisa, Penedo, Frank, Perreira, Krista, Pirzada, Amber, Schneiderman, Neil, Wassertheil-Smoller, Sylvia, Sorlie, Paul D, Stamler, Jeremiah

“…CONTEXT Major cardiovascular diseases (CVDs) are leading causes of mortality among US Hispanic and Latino individuals. Comprehensive data are limited regarding…”
Get full text

Depression, anxiety, antidepressant use, and cardiovascular disease among Hispanic men and women of different national backgrounds: results from the Hispanic Community Health Study/Study of Latinos by Wassertheil-Smoller, Sylvia, PhD, Arredondo, Elva M., PhD, Cai, JianWen, PhD, Castaneda, Sheila F., PhD, Choca, James P., PhD, Gallo, Linda C., PhD, Jung, Molly, MPH, LaVange, Lisa M., PhD, MAc, Lee-Rey, Elizabeth T., MD, MPH, Mosley, Thomas, PhD, Penedo, Frank J., PhD, Santistaban, Daniel A., PhD, Zee, Phyllis C., PhD, MD

“…Abstract Purpose To describe prevalence and relationships to cardiovascular morbidity of depression, anxiety, and medication use among Hispanic/Latinos of…”
Get full text

Advancing precision medicine for acute respiratory distress syndrome by Beitler, Jeremy R, Thompson, B Taylor, Baron, Rebecca M, Bastarache, Julie A, Denlinger, Loren C, Esserman, Laura, Gong, Michelle N, LaVange, Lisa M, Lewis, Roger J, Marshall, John C, Martin, Thomas R, McAuley, Daniel F, Meyer, Nuala J, Moss, Marc, Reineck, Lora A, Rubin, Eileen, Schmidt, Eric P, Standiford, Theodore J, Ware, Lorraine B, Wong, Hector R, Aggarwal, Neil R, Calfee, Carolyn S

“…Acute respiratory distress syndrome (ARDS) is a heterogeneous clinical syndrome. Understanding of the complex pathways involved in lung injury pathogenesis,…”
Get full text

Standardizing nasal nitric oxide measurement as a test for primary ciliary dyskinesia by Leigh, Margaret W, Hazucha, Milan J, Chawla, Kunal K, Baker, Brock R, Shapiro, Adam J, Brown, David E, Lavange, Lisa M, Horton, Bethany J, Qaqish, Bahjat, Carson, Johnny L, Davis, Stephanie D, Dell, Sharon D, Ferkol, Thomas W, Atkinson, Jeffrey J, Olivier, Kenneth N, Sagel, Scott D, Rosenfeld, Margaret, Milla, Carlos, Lee, Hye-Seung, Krischer, Jeffrey, Zariwala, Maimoona A, Knowles, Michael R

“…Several studies suggest that nasal nitric oxide (nNO) measurement could be a test for primary ciliary dyskinesia (PCD), but the procedure and interpretation…”
Get full text

Efficacy of infliximab, abatacept, and cenicriviroc for the treatment of adults hospitalized with COVID-19 pneumonia by Lin, Dan-Yu, Wang, Jianqiao, Anstrom, Kevin J., LaVange, Lisa M., Wen, Jun, Bozzette, Samuel A., Powderly, William G.

“…•A randomized clinical trial was conducted on patients hospitalized with COVID-19.•The patient's clinical status was assessed daily on an 8-point ordinal…”
Get full text

Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort by Hastie, Annette T, Martinez, Fernando J, Curtis, Jeffrey L, Doerschuk, Claire M, Hansel, Nadia N, Christenson, Stephanie, Putcha, Nirupama, Ortega, Victor E, Li, Xingnan, Barr, R Graham, Carretta, Elizabeth E, Couper, David J, Cooper, Christopher B, Hoffman, Eric A, Kanner, Richard E, Kleerup, Eric, O'Neal, Wanda K, Paine, Richard, Peters, Stephen P, Alexis, Neil E, Woodruff, Prescott G, Han, MeiLan K, Meyers, Deborah A, Bleecker, Eugene R, Alexis, Neil E, Anderson, Wayne H, Barr, R Graham, Bleecker, Eugene R, Boucher, Richard C, Bowler, Russell P, Carretta, Elizabeth E, Christenson, Stephanie A, Comellas, Alejandro P, Cooper, Christopher B, Couper, David J, Criner, Gerard J, Crystal, Ronald G, Curtis, Jeffrey L, Doerschuk, Claire M, Dransfield, Mark T, Freeman, Christine M, Han, MeiLan K, Hansel, Nadia N, Hastie, Annette T, Hoffman, Eric A, Kaner, Robert J, Kanner, Richard E, Kleerup, Eric C, Krishnan, Jerry A, LaVange, Lisa M, Lazarus, Stephen C, Martinez, Fernando J, Meyers, Deborah A, Newell, John D, Oelsner, Elizabeth C, O'Neal, Wanda K, Paine, Robert, Putcha, Nirupama, Rennard, Stephen I., Tashkin, Donald P, Scholand, Mary Beth, Wells, J Michael, Wise, Robert A, Woodruff, Prescott G

“…Increased concentrations of eosinophils in blood and sputum in chronic obstructive pulmonary disease (COPD) have been associated with increased frequency of…”
Get full text

A Randomized Trial Examining the Effectiveness of Switching From Olanzapine, Quetiapine, or Risperidone to Aripiprazole to Reduce Metabolic Risk: Comparison of Antipsychotics for Metabolic Problems (CAMP) by Stroup, T. Scott, McEvoy, Joseph P., Ring, Kimberly D., Hamer, Robert H., LaVange, Lisa M., Swartz, Marvin S., Rosenheck, Robert A., Perkins, Diana O., Nussbaum, Abraham M., Lieberman, Jeffrey A.

“…Patients with a BMI of 27 or higher and a non-HDL cholesterol level of 130 mg/dl or higher on stable doses of olanzapine, quetiapine, or risperidone were…”
Get full text

Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort by Han, MeiLan K, Quibrera, Pedro M, Carretta, Elizabeth E, Barr, R Graham, Bleecker, Eugene R, Bowler, Russell P, Cooper, Christopher B, Comellas, Alejandro, Couper, David J, Curtis, Jeffrey L, Criner, Gerard, Dransfield, Mark T, Hansel, Nadia N, Hoffman, Eric A, Kanner, Richard E, Krishnan, Jerry A, Martinez, Carlos H, Pirozzi, Cheryl B, O'Neal, Wanda K, Rennard, Stephen, Tashkin, Donald P, Wedzicha, Jadwiga A, Woodruff, Prescott, Paine, Robert, Martinez, Fernando J, Alexis, Neil E, Anderson, Wayne H, Barr, R Graham, Bleecker, Eugene R, Boucher, Richard C, Bowler, Russell P, Carretta, Elizabeth E, Christenson, Stephanie A, Comellas, Alejandro P, Cooper, Christopher B, Couper, David J, Criner, Gerard J, Crystal, Ronald G, Curtis, Jeffrey L, Doerschuk, Claire M, Dransfield, Mark T, Freeman, Christine M, Han, MeiLan K, Hansel, Nadia N, Hastie, Annette T, Hoffman, Eric A, Kaner, Robert J, Kanner, Richard E, Kleerup, Eric C, Krishnan, Jerry A, LaVange, Lisa M, Lazarus, Stephen C, Martinez, Fernando J, Meyers, Deborah A, Newell, John D, Oelsner, Elizabeth C, O'Neal, Wanda K, Paine, Robert, Putcha, Nirupama, Rennard, Stephen I., Tashkin, Donald P, Scholand, Mary Beth, Wells, J Michael, Wise, Robert A, Woodruff, Prescott G

“…Present treatment strategies to stratify exacerbation risk in patients with chronic obstructive pulmonary disease (COPD) rely on a history of two or more…”
Get full text

Prevalence of Hypertension, Awareness, Treatment, and Control in the Hispanic Community Health Study/Study of Latinos by Sorlie, Paul D., Allison, Matthew A., Avilés-Santa, M. Larissa, Cai, Jianwen, Daviglus, Martha L., Howard, Annie G., Kaplan, Robert, LaVange, Lisa M., Raij, Leopoldo, Schneiderman, Neil, Wassertheil-Smoller, Sylvia, Talavera, Gregory A.

“…BACKGROUND The prevention and control of hypertension is an essential component for reducing the burden of cardiovascular diseases. Here we describe the…”
Get full text

PrecISE: Precision Medicine in Severe Asthma: An adaptive platform trial with biomarker ascertainment by Israel, Elliot, Denlinger, Loren C., Bacharier, Leonard B., LaVange, Lisa M., Moore, Wendy C., Peters, Michael C., Georas, Steve N., Wright, Rosalind J., Mauger, David T., Noel, Patricia, Akuthota, Praveen, Bach, Julia, Bleecker, Eugene R., Cardet, Juan Carlos, Carr, Tara F., Castro, Mario, Cinelli, Angeles, Comhair, Suzy A.A., Covar, Ronina A., Alexander, Laura Crotty, DiMango, Emily A., Erzurum, Serpil C., Fahy, John V., Fajt, Merritt L., Gaston, Benjamin M., Hoffman, Eric A., Holguin, Fernando, Jackson, Daniel J., Jain, Sonia, Jarjour, Nizar N., Ji, Yuan, Kenyon, Nicholas J., Kosorok, Michael R., Kraft, Monica, Krishnan, Jerry A., Kumar, Rajesh, Liu, Andrew H., Liu, Mark C., Ly, Ngoc P., Marquis, M. Alison, Martinez, Fernando D., Moy, James N., O’Neal, Wanda K., Ortega, Victor E., Peden, David B., Phipatanakul, Wanda, Ross, Kristie, Smith, Lewis J., Szefler, Stanley J., Teague, W. Gerald, Tulchinsky, Abigail F., Vijayanand, Pandurangan, Wechsler, Michael E., Wenzel, Sally E., White, Steven R., Zeki, Amir A., Ivanova, Anastasia

“…Severe asthma accounts for almost half the cost associated with asthma. Severe asthma is driven by heterogeneous molecular mechanisms. Conventional clinical…”
Get full text